All sites C00-96,D32-33,D42-43,D45-47,D76 87 88.5 3.7 2.8 0.9 4.2
Mouth, pharynx C00-14 1 100.0 - - - -
  Lip C00 - - - - - -
  Tongue C02 0 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 - - - - - -
  Pharynx C01,C09-14 0 100.0 - - - -
Digestive organs C15-26 17 86.0 2.3 5.8 1.2 4.7
  Oesophagus C15 1 100.0 - - - -
  Stomach C16 1 100.0 - - - -
  Small intestine C17 0 100.0 - - - -
  Colon C18 7 94.3 - 2.9 2.9 -
  Rectum, rectosigmoid C19-20 3 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 1 66.7 33.3 - - -
  Gallbladder, bile ducts C23-24 1 100.0 - - - -
  Pancreas C25 2 54.5 - 36.4 - 9.1
  Other digestive organs C26 1 - - - - 100.0
Respiratory organs C30-39 6 78.6 17.9 - - 3.6
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 6 78.6 17.9 - - 3.6
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 5 100.0 - - - -
Skin, non-melanoma C44 6 96.9 3.1 - - -
Mesothelioma C45 - - - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 0 100.0 - - - -
Breast C50 24 99.2 0.8 - - -
Female genital organs C51-58 10 80.8 1.9 7.7 3.8 5.8
  Cervix uteri C53 1 100.0 - - - -
  Corpus uteri C54 3 94.1 - - - 5.9
  Uterus, other C55,C58 0 - - - 100.0 -
  Ovary C56 4 71.4 4.8 14.3 4.8 4.8
  Other female genital C51-52,C57 2 75.0 - 12.5 - 12.5
Urinary organs C64-68 3 71.4 - 14.3 - 14.3
  Kidney C64 2 66.7 - 22.2 - 11.1
  Bladder and urinary tract2 C65-68 1 80.0 - - - 20.0
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 3 69.2 - - - 30.8
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 3 76.9 15.4 - - 7.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 7 72.7 12.1 3.0 3.0 9.1
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 4 94.4 - - - 5.6
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 2 50.0 25.0 12.5 - 12.5
  Leukaemia C91-95 1 25.0 50.0 - 25.0 -
  Myelodysplastic syndromes D46 0 - - - - 100.0
  Myeloproliferaitive neoplasms D45,D47 0 100.0 - - - -
Not included above
  Carcinoma in situ of the breast D05 2 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 8 100.0 - - - -
  Borderline tumour of the ovary D39 1 100.0 - - - -
  Basal cell carcinoma of the skin 42 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.